1 – 15 of 15
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy : A report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)
(
- Contribution to journal › Article
- 2015
-
Mark
Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men
(
- Contribution to journal › Article
- 2014
-
Mark
One Course of Adjuvant BEP in Clinical Stage I Nonseminoma Mature and Expanded Results from the SWENOTECA group.
(
- Contribution to journal › Article
- 2013
-
Mark
Prognostic sub-classifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion. Results of a population-based study from the Swedish Melanoma Register.
(
- Contribution to journal › Article
-
Mark
Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: A nationwide population-based study in Sweden
(
- Contribution to journal › Article
- 2011
-
Mark
Feelings of loss and uneasiness or shame after removal of a testicle by orchidectomy: a population-based long-term follow-up of testicular cancer survivors
(
- Contribution to journal › Article
-
Mark
High-dose Chemotherapy With Autologous Stem-cell Support in Patients With Metastatic Non-seminomatous Testicular Cancer - a Report From the Swedish Norwegian Testicular Cancer Group (SWENOTECA)
2011) European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care In European Journal of Cancer 47. p.507-508(
- Contribution to journal › Published meeting abstract
- 2010
-
Mark
Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study
(
- Contribution to journal › Article
- 2009
-
Mark
LONG-TERM IMPAIRED LANGUAGE AND DECREASED WELL-BEING AMONG TESTICULAR CANCER SURVIVORS WHO RECEIVED CHEMOTHERAPY - RESULTS FROM SWENOTECA
2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.358-358(
- Contribution to journal › Published meeting abstract
-
Mark
Individualized intensification of treatment based on tumor marker decline in metastatic nonseminomatous germ cell testicular cancer (NSGCT): A report from the Swedish Norwegian Testicular Cancer Group, SWENOTECA
2009) 45th Annual Meeting of the American-Society-of-Clinical-Oncology In Journal of Clinical Oncology 27(15).(
- Contribution to journal › Published meeting abstract
-
Mark
Feelings of loss and shame after having lost a testicle: a population-based long-term follow-up of testicular-cancer survivors
2009) 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology In EJC Supplements 7(2). p.445-445(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Self-reported cognitive function among testicular cancer survivors treated with chemotherapy
(
- Contribution to journal › Published meeting abstract
-
Mark
a multicentre, phase ii study of cp-4055 in combination with sorafenib in patients with metastatic malignant melanoma
(
- Contribution to journal › Published meeting abstract
- 2004
-
Mark
Invasive cutaneous malignant melanoma in Sweden, 1990-1999 - A prospective, population-based study of survival and prognostic factors
(
- Contribution to journal › Article
- 1998
-
Mark
Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial
(
- Contribution to journal › Article